News for InspireMD, Inc. (NSPR-WT)

Published at

Mar 13, 2025 8:04 AM

by gurufocus.com

positive

positive

InspireMD Inc (NSPR) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Rising Expenses and Strategic US Launch Preparations

Revenue (Q4 2024): $1.95 million, a 10.6% increase year-over-year.Full Year Revenue (2024): $7 million, a 13% increase from 2023.Gross Profit (Q4 2024): $469,0

NSPR-WT NSPR

Read more →
Published at

Mar 13, 2025 6:18 AM

by gurufocus.com

positive

positive

Q4 2024 InspireMD Inc Earnings Call Transcript

Mar 12, 2025 / 12:30PM GMTOperator Please standby. Your program is about to begin. (Operator Instructions) Hello, and welcome to InspireMD's fourth-quarter 2024

NSPR-WT NSPR

Read more →
Published at

Mar 12, 2025 6:53 PM

by seekingalpha.com

positive

positive

InspireMD, Inc. (NSPR) Q4 2024 Earnings Call Transcript

NSPR (NASDAQ:NSPR) Q4 2024 Earnings Conference Call March 12, 2025 8:30 AM ETCompany ParticipantsMarvin Slosman - CEOCraig Shore - CFOShane Gleason -...

NSPR-WT NSPR

Read more →
Published at

Mar 12, 2025 1:10 PM

by zacks.com

positive

positive

InspireMD, Inc. (NSPR) Reports Q4 Loss, Tops Revenue Estimates

InspireMD (NSPR) delivered earnings and revenue surprises of 5% and 6.50%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

NSPR-WT NSPR

Read more →
Published at

Mar 12, 2025 12:22 PM

by manilatimes.net

positive

positive

InspireMD Reports Fourth Quarter and Full Year 2024 Financial Results

**media[564212]**

NSPR-WT NSPR

Read more →
Published at

Feb 26, 2025 2:00 PM

by gurufocus.com

positive

positive

InspireMD to Announce Fourth Quarter and Full Year 2024 Financial Results

MIAMI, Feb. 26, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. ( NSPR), developer of the CGuardâ„¢ Prime carotid stent system for the treatment of carotid artery di

NSPR-WT NSPR

Read more →
Published at

Feb 25, 2025 2:15 PM

by manilatimes.net

positive

positive

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

**media[549752]**

NSPR-WT NSPR

Read more →
Published at

Feb 25, 2025 2:00 PM

by gurufocus.com

positive

positive

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MIAMI, Feb. 25, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. ( NSPR), developer of the CGuardâ„¢ Prime carotid stent system for the prevention of stroke, today an

NSPR-WT NSPR

Read more →
Published at

Feb 15, 2025 11:30 AM

by gurufocus.com

positive

positive

Nantahala Capital Management, LLC Increases Stake in InspireMD Inc

On December 31, 2024, Nantahala Capital Management, LLC (Trades, Portfolio) made a significant move by increasing its stake in InspireMD Inc (NSPR). The firm ad

SLNO PTON.MX PTON NSPR-WT NSPR ESTA EOLS BVS 0K16.L

Read more →
Published at

Feb 13, 2025 1:00 PM

by gurufocus.com

positive

positive

InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal Clinical Trial of the CGuard Prime™ 80 cm Carotid Stent System for Use in TCAR procedures

TOLEDO, Ohio and MIAMI, Feb. 13, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. ( NSPR), developer of the CGuardâ„¢ Prime Carotid Stent System for the prevention of

NSPR-WT NSPR

Read more →
Published at

Feb 7, 2025 7:26 PM

by gurufocus.com

positive

positive

Rosalind Advisors, Inc. Expands Stake in InspireMD Inc.

On December 31, 2024, Rosalind Advisors, Inc. (Trades, Portfolio) significantly increased its investment in InspireMD Inc. by acquiring an additional 7,419,918

NSPR-WT NSPR DCTH CRMD ABEO 0H7R.L

Read more →
Published at

Feb 4, 2025 1:15 PM

by manilatimes.net

positive

positive

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

**media[531558]**

NSPR-WT NSPR

Read more →
Published at

Jan 21, 2025 1:00 PM

by gurufocus.com

positive

positive

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MIAMI, Jan. 21, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. ( NSPR), developer of the CGuardâ„¢ Prime carotid stent system for the prevention of stroke, today an

NSPR-WT NSPR

Read more →
Published at

Dec 12, 2024 1:04 PM

by investing.com

positive

positive

InspireMD CFO Craig Shore to retire, successor search underway By Investing.com

InspireMD CFO Craig Shore to retire, successor search underway

NSPR-WT NSPR

Read more →
Published at

Dec 12, 2024 1:00 PM

by gurufocus.com

positive

positive

InspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025

MIAMI, Dec. 12, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. ( NSPR), developer of the CGuardâ„¢ Embolic Prevention Stent System (EPS) for the prevention of strok

NSPR-WT NSPR

Read more →
Published at

Dec 9, 2024 1:23 PM

by manilatimes.net

positive

positive

InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures (TCAR)

**media[487010]**

NSPR-WT NSPR

Read more →
Published at

Dec 9, 2024 1:00 PM

by gurufocus.com

positive

positive

InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures (TCAR)

Study represents a significant step forward in Company's mission to serve the broadest set of physician and patient needs with best-in-class CAS and TCAR solut

NSPR-WT NSPR

Read more →
Published at

Nov 25, 2024 11:00 PM

by gurufocus.com

positive

positive

InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to its Board of Directors

MIAMI, Nov. 25, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. ( NSPR), developer of the CGuardâ„¢ Embolic Prevention Stent System (EPS) for the prevention of strok

NSPR-WT NSPR CSII

Read more →
Published at

Nov 12, 2024 4:20 PM

by seekingalpha.com

positive

positive

InspireMD, Inc. (NSPR) Q3 2024 Earnings Call Transcript

InspireMD, Inc. (NASDAQ:NSPR) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ETCompany ParticipantsChuck Padala - IR, Life AdvisorsMarvin...

NSPR-WT NSPR

Read more →
Published at

Nov 12, 2024 2:25 PM

by zacks.com

positive

positive

InspireMD, Inc. (NSPR) Reports Q3 Loss, Tops Revenue Estimates

InspireMD (NSPR) delivered earnings and revenue surprises of 20% and 4.02%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

NSPR-WT NSPR

Read more →